Lumina Fund Management LLC - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLU and the CUSIP is 81369Y886. A total of 403 filers reported holding SELECT SECTOR SPDR TR in Q3 2014. The put-call ratio across all filers is 2.03 and the average weighting 0.4%.

Quarter-by-quarter ownership
Lumina Fund Management LLC ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$295
-100.0%
5,000
-93.6%
0.10%
-71.8%
Q1 2018$3,967,000
-4.1%
78,5000.0%0.36%
-7.1%
Q4 2017$4,135,000
-0.7%
78,5000.0%0.38%
-10.5%
Q3 2017$4,164,000
+2.1%
78,5000.0%0.43%
+59.9%
Q2 2017$4,079,000
+1.3%
78,5000.0%0.27%
-46.8%
Q1 2017$4,028,000
+5.6%
78,5000.0%0.50%
+24.6%
Q4 2016$3,813,000
-0.9%
78,5000.0%0.40%
-2.4%
Q3 2016$3,846,000
-6.6%
78,5000.0%0.41%
+29.1%
Q2 2016$4,119,000
+5.8%
78,5000.0%0.32%
-31.0%
Q1 2016$3,895,000
+14.7%
78,5000.0%0.46%
+59.5%
Q4 2015$3,397,000
-0.0%
78,5000.0%0.29%
+11.5%
Q3 2015$3,398,000
+4.4%
78,5000.0%0.26%
+31.8%
Q2 2015$3,255,000
-6.7%
78,5000.0%0.20%
-48.6%
Q1 2015$3,488,000
-5.9%
78,5000.0%0.38%
+23.8%
Q4 2014$3,707,000
+12.2%
78,5000.0%0.31%
+2.3%
Q3 2014$3,304,000
-4.9%
78,5000.0%0.30%
+84.2%
Q2 2014$3,474,000
+0.7%
78,500
-5.6%
0.16%
-59.1%
Q1 2014$3,450,000
+9.2%
83,2000.0%0.40%
+23.6%
Q4 2013$3,159,000
+1.6%
83,2000.0%0.33%
+23.0%
Q3 2013$3,108,000
-0.7%
83,2000.0%0.26%
+31.2%
Q2 2013$3,131,00083,2000.20%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q3 2014
NameSharesValueWeighting ↓
Axel Capital Management, LLC 926,000$53,865,00028.68%
Covalis Capital LLP 489,496$28,474,00026.42%
Price Capital Management, Inc. 1,090,637$63,442,00017.72%
Wechter Feldman Wealth Management, Inc. 402,654$23,422,00015.29%
Michael & Susan Dell Foundation 265,773$15,460,00014.91%
Julex Capital Management, LLC 247,547$14,399,808,00012.48%
Florin Court Capital LLP 496,400$28,876,00012.38%
Q3 Asset Management 1,236,890$4,398,00011.85%
Boothe Investment Group, Inc. 133,482$7,765,0009.68%
Columbus Hill Capital Management, L.P. 1,500,000$87,255,0007.92%
View complete list of SELECT SECTOR SPDR TR shareholders